HighlightsHypoxia-activated prodrugs have yielded promising results up to phase II trials.Implementation of hypoxia-activated prodrugs in the clinic has not been successful.Phase III clinical trials lack patient stratification based on tumor hypoxia status.Stratification will decrease the number of patients needed and increase success.Improvements in hypoxia-activated prodrug design can also increase success rates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.